BTC$64,155.00-0.68%
ETH$1,886.81+0.61%
USDT$0.99920.00%
BNB$577.19-0.02%
USDC$1.+0.01%
XRP$1.11+0.01%
SOL$76.16-1.54%
TRX$0.3232-1.50%
FIGR_HELOC$1.04+0.05%
HYPE$65.90-2.82%
DOGE$0.0732-0.55%
USDS$0.9998+0.01%
RAIN$0.0143-2.25%
ZEC$545.55-3.24%
LEO$9.81+0.27%
WBT$56.18-0.43%
BTC$64,155.00-0.68%
ETH$1,886.81+0.61%
USDT$0.99920.00%
BNB$577.19-0.02%
USDC$1.+0.01%
XRP$1.11+0.01%
SOL$76.16-1.54%
TRX$0.3232-1.50%
FIGR_HELOC$1.04+0.05%
HYPE$65.90-2.82%
DOGE$0.0732-0.55%
USDS$0.9998+0.01%
RAIN$0.0143-2.25%
ZEC$545.55-3.24%
LEO$9.81+0.27%
WBT$56.18-0.43%
UnitedHealth reported Q3 revenue of $113.2 billion and EPS of $2.92, beating estimates and raising its full-year outlook.
Alliance Resource Partners reported Q3 2025 revenue of $571.4 million and EPS of $0.73, exceeding estimates and tightening its full-year guidance.
Keurig Dr Pepper exceeded expectations with Q3 revenue of $4.31 billion and EPS of $0.54 and raised its full-year net sales guidance.
Revvity reported Q3 2025 revenue of $699 million, slightly below expectations, while adjusted EPS of $1.18 topped forecasts, prompting a full-year guidance raise.
ITW reported Q3 2025 revenue of $4.1 billion and EPS of $2.81, both above expectations.
Procter & Gamble reported Q1 2026 net sales of $22.4 billion and EPS of $1.95, up 21% year over year.
General Dynamics beat Q3 2025 estimates with revenue of $12.9 billion and EPS of $3.88, supported by strong aerospace demand and solid growth across all segments.
Roper Technologies reported Q3 2025 revenue of $2.02 billion, up 14% year-over-year, and adjusted EPS of $5.14, slightly above estimates.
T-Mobile beat Q3 expectations with revenue of $21.96 billion and EPS of $2.41, raising its full-year outlook on record customer growth and strong demand.
Honeywell beat Q3 expectations with 7% sales growth and adjusted EPS of $2.82, raising its full-year outlook.
Netflix shares fell over 8% after Q3 earnings missed estimates, with EPS of $5.87 impacted by a $619 million Brazil tax charge despite record revenue.
AT&T reported Q3 2025 revenue of $30.7 billion and adjusted EPS of $0.54, slightly missing estimates but supported by strong wireless and fiber customer growth.
Boston Scientific reported Q3 2025 net sales of $5.07 billion and adjusted EPS of $0.75, topping expectations and supporting its upbeat full-year guidance.